LGD-4033 (Ligandrol)
Shop LGD-4033 (Ligandrol) on KimeraChems · code GUIDE (10% off)Definition
LGD-4033, also known as Ligandrol, is a synthetic selective androgen receptor modulator (SARM) originally developed to investigate treatment for muscle wasting, osteoporosis, and hormone-related conditions. It selectively binds androgen receptors in muscle and bone tissue with high affinity, producing significant anabolic signals without the full androgenic burden associated with traditional anabolic steroids. Among SARMs, LGD is widely regarded as one of the more effective bulking-oriented compounds in preclinical and observational research contexts, producing muscle volumization and fullness signals that are often compared in character to wet oral androgen effects due to water retention and tissue volumization observations. It is also noted as relatively joint-friendly and hair-safe compared to more androgenic compounds based on its selective receptor profile. LGD-4033 is not approved for human or veterinary use and is supplied strictly for laboratory research purposes.
Available Formats
- 30 mL liquid solution
- Dry fill capsules
- Tablets
- 10 mL aliquot vial (MCT oil carrier)
- 1 gram powder
Mechanism of Action
- High-affinity androgen receptor binding selectively activating androgen receptors in muscle and bone tissue, driving anabolic gene transcription, nitrogen retention, and protein synthesis without broad systemic androgenic activity.
- Muscle volumization and glycogen retention contributing to the full tissue appearance LGD is associated with in research contexts, which also produces a joint-protective signal by increasing lubrication and cushioning observations in connective tissue models.
- Endogenous testosterone suppression via HPG axis feedback inhibition, with LGD producing meaningful suppression of LH and FSH in studied models, with endocrine recovery protocol design remaining a relevant consideration after extended exposure windows.
- Bone density support through androgen receptor activity in skeletal tissue, consistent with its original medical research context targeting osteoporosis and muscle wasting conditions.
Areas of Investigation
- Muscle mass and hypertrophy endpoints with LGD widely considered the most effective bulking-oriented SARM in preclinical research, associated with substantial lean mass accumulation signals within standard 8 to 10 week exposure windows.
- Tissue volumization and aesthetics with the signature LGD observation being a full, powerful tissue appearance driven by muscle fullness and water retention signals, similar in character to wet oral androgen models.
- Recovery and training output signals with reduced muscle soreness markers and faster recovery readouts reported in certain observational contexts, supporting higher frequency research designs.
- Joint protection signals with the water retention LGD produces providing meaningful connective tissue cushioning observations, making it a relevant variable in designs where joint stress is a monitored endpoint compared to drier compounds like RAD-140.
- Hair-safe androgenic profile with LGD considered one of the more follicle-friendly options in the SARM category based on its selective receptor binding, relevant in designs monitoring androgenic alopecia markers.
- Mild androgenic signal profile compared to traditional anabolic steroids, with significantly reduced virilization, prostate stimulation, and hair loss observations at studied dose ranges.
Safety Profile
- Testosterone suppression the primary monitored concern, with LGD producing significant HPG axis suppression in research models, requiring endocrine recovery protocol consideration after each exposure window.
- Water retention and blood pressure elevation driven by the volumizing effect of LGD, which can produce cardiovascular stress signals particularly at higher dose designs.
- Cardiovascular and lipid profile shifts including potential cholesterol marker changes warranting regular monitoring as a standard variable, especially in longer exposure designs.
- Mild androgenic signals including possible acne and libido changes observed in certain model contexts, though less pronounced than with traditional androgenic compounds.
- Regulatory and competitive sport considerations as LGD is classified as a prohibited substance by most major sports organizations and is banned in competitive athletics contexts.
For educational purposes only. Not for human consumption.